New Arrival 2022! Excimer System 308 nm Professional Phototherapy Device CN-308D Series with Durable SMD LED Light Source.
Phototherapy indications of this device are: Vitiligo, Psoriasis, Eczema, Pityriasis, Dermatitis and other skin disorders.
Privileges:
- It have MED test to find out the right time or dose of irradiation, so that optimal results are obtained
- Working Mode: Timing and Dosing Mode, providing a choice of photo therapy convenience and comfort
- Treatment records, making it easier for you to find out the treatment records and proceed
- Voice prompt, minimizing potential errors by voicing your preferred dose
- Fingerprint management, convenient for doctors to quickly retrieve patient information
Professional Device 308nm UV Excimer System CN-308D uses a light source from LED made in Japan. Safe and durable, suitable for treatment of Vitiligo, Psoriasis, Dermatitis, Eczema, Pityriasis rosea and other skin disorders.
Features:
- UV SMD LED as light source, high stability and long life
- The device wand is comfortable to grip for flexible irradiation
- Strong targeting and simple operation, good for use in clinics and hospitals, also suitable for home treatment
- Built-in MED test program, convenient for users to test themselves, get the right irradiation dose
- Colorful touch LCD screen, two treatment modes, dose mode and time mode. It is optional, users can choose which one is convenient to operate
- Humanized voice prompt function, more comfortable and pleasant treatment experience. Minimizes the potential for false timing or radiation dose
- Various shapes of masks, suitable for different sizes of lesion parts, avoid exposure to healthy skin
- Fingerprint entry function, convenient for doctors to quickly retrieve patient information
Parameter:
Model: CN-308D
Light source: SMD UV LED made in Japan
UVB wavelength: 308nm ± 2nm
Language: English (US)
Indication:
Vitiligo, Psoriasis, Dermatitis, Eczema, Pitiriasis rosea and other skin disorder
Output intensity:
40 mW/cm2
Irradiation area 20 cm2 ± 10%
What others are saying
There are no contributions yet.